Journal of Cancer Research and Clinical Oncology

Article	Citations
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma	96
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning	94
Estimating the global burden of Epstein–Barr virus-related cancers	86
Role of lung and gut microbiota on lung cancer pathogenesis	82
Artificial intelligence in gastric cancer: a systematic review	69
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review	66
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients	59
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study	57
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy	53
Cannabinoids in the landscape of cancer	52
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters	51
Gut microbiota-derived metabolites in CRC progression and causation	49
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression	45
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer	42
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes	38
Cancer patients’ perspective on shared decision-making and decision aids in oncology	37
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells	37
Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art	36
3D tumor angiogenesis models: recent advances and challenges	35
Oncology services in corona times: a flash interview among German cancer patients and their physicians	35
Targeting tumor vascularization: promising strategies for vascular normalization	34
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	33
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials	32
Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis	31
CD36: an emerging therapeutic target for cancer and its molecular mechanisms	31

Implications of flavonoids as potential modulators of cancer neovascularity	31
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression	31
Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature	30
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments	30
Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma	30
Predictive biomarkers in gastric cancer	30
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT	29
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observati	29
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review	29
Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies	29
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA	29
Current trends of targeted therapy for oral squamous cell carcinoma	28
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas	28
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma	28
Melatonin: an endogenous miraculous indolamine, fights against cancer progression	28
Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma	27
MAPK signaling pathway-targeted marine compounds in cancer therapy	27
Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome	27
Inflammatory markers in autoimmunity induced by checkpoint inhibitors	26
The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation	26
High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)	26
Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential	25
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing	25
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma	25
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board	25
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	25
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes	24
The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma	24
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning	23
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis	23
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data	23
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy	23
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort	23
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer	23
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy	22
Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning	22
Human TERT promoter mutations as a prognostic biomarker in glioma	22
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	22
PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions	21
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases	21
Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation	21
Large language models for oncological applications	21
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics	21
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective singl	21
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis	21
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer	21
Active HPV infection and its influence on survival in head and neck squamous-cell cancer	21
Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI	20
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer	20
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma	20

Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective	20
Radiotherapy resistance: identifying universal biomarkers for various human cancers	20
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California	20
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways	19
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer	19
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death	19
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China	19
Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis	19
Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer	19
Multiple functions of p21 in cancer radiotherapy	19
Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis	19
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach	19
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma	19
Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors	19
Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects	19
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres	18
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients	18
TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction	18
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin	18
Risk of lung cancer and renin–angiotensin blockade: a concise review	18
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer	18
Triple negative breast cancer: approved treatment options and their mechanisms of action	18
Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study	18
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy	18
SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis	17
Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis	17
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China	17
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer	17
Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer	17
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy	17
First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation	17
Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes	17
Tumor patients’ fears and worries and perceived changes of specific attitudes, perceptions and behaviors due to the COVID-19 pandemic are still relevant	17
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey	17
Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare	16
Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements	16
Expression of H3K4me3 and H3K9ac in breast cancer	16
Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma	16
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020	16
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers	16
Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries	16
Immunological combination treatment holds the key to improving survival in pancreatic cancer	16
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis	16
Molecular targeted treatment and drug delivery system for gastric cancer	16
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing	16
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review	16
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results	16
Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany	16
An overview and a roadmap for artificial intelligence in hematology and oncology	16
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma	16
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity	16
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network	15
Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer	15
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer	15
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells	15
Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection	15
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance	15
The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review	15
Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1	15
Cancer risks in patients with vitiligo: a Mendelian randomization study	15
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis	15
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling	15
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1	15
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment	15
Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma	15
Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis	14
Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification	14
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma	14
Aurora B kinase: a potential drug target for cancer therapy	14
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small	14
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial	14
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)	14
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study	14
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer	14
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases	14
IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer	14
Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms	14
Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer	14
Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC	13
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma	13

Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling	13
SWI/SNF chromatin remodeling complex alterations in meningioma	13
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres	13
Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection	13
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis	13
Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment	13
Genomic landscape of colorectal carcinogenesis	13
BDNF and its signaling in cancer	13
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases	13
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized	13
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia	13
Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes	13
Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral res	13
Ten–eleven translocase: key regulator of the methylation landscape in cancer	13
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C	13
Cancer-associated inflammation: pathophysiology and clinical significance	13
Association between various thyroid gland diseases, TSH values and thyroid cancer: a case–control study	12
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT	12
Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules	12
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities	12
Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion	12
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience	12
EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis	12
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases	12
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma	12
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis	12
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study	12
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome	12
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping	12
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications	12
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers	12
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma	12
Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results	12
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity	12
Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma	12
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study	12
Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients	12
Water therapies (hydrotherapy, balneotherapy or aqua therapy) for patients with cancer: a systematic review	12
G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival	12
Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy	12
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study	12
UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines	12
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease	12
N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression	11
Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors	11
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases	11
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression	11
Machine learning and deep learning techniques for breast cancer diagnosis and classification: a comprehensive review of medical imaging studies	11
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer	11
Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells	11
Expression of estrogen-related receptors in ovarian cancer and impact on survival	11
Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma	11
Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents	11
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer	11
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis	11
Gamma-delta T cells stimulate IL-6 production by pancreatic stellate cells in pancreatic ductal adenocarcinoma	11
Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1	11
Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database	11
Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review	11
Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers	11
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care	11
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard tre	11
Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing	11
Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1	11
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients	11
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project	11
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers	11
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors	10
Applications of artificial intelligence multiomics in precision oncology	10
Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma	10
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)	10
Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis	10
Three-dimensional models: a novel approach for lymphoma research	10
Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost	10
Targeted therapy for osteosarcoma: a review	10
Experimental and clinical studies on radiation and curcumin in human glioma	10
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B	10
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer	10
Cancer immune escape: the role of antigen presentation machinery	10
Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series	10
Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma	10
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation	10
Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis	10
Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study	10
Activation-induced cytidine deaminase: in sickness and in health	10
Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma	10
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review	10
Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP	10
Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors	10
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities	10
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)	10
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer	10
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group	10
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a	10
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time	10